| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.08 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.09 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |